Synonym
ST-271; ST271; ST 271.
IUPAC/Chemical Name
(E)-2-Cyano-3-[4-hydroxy-3,5-di(propan-2-yl)phenyl]prop-2-enamide
InChi Key
HMLQHJRJKQDTKW-LFYBBSHMSA-N
InChi Code
InChI=1S/C16H20N2O2/c1-9(2)13-6-11(5-12(8-17)16(18)20)7-14(10(3)4)15(13)19/h5-7,9-10,19H,1-4H3,(H2,18,20)/b12-5+
SMILES Code
O=C(N)/C(C#N)=C/C1=CC(C(C)C)=C(O)C(C(C)C)=C1
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
272.34
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Hjálmarsdóttir MÁ, Kristinsson KG. Epidemiology of penicillin-non-susceptible pneumococci in Iceland, 1995-2010. J Antimicrob Chemother. 2014 Apr;69(4):940-6. doi: 10.1093/jac/dkt470. Epub 2013 Dec 5. PubMed PMID: 24311742.
2: Bean DC, Klena JD. Characterization of major clones of antibiotic-resistant Streptococcus pneumoniae in New Zealand by multilocus sequence typing. J Antimicrob Chemother. 2005 Mar;55(3):375-8. Epub 2005 Jan 28. PubMed PMID: 15681581.
3: Ohno R. [Tyrosine kinase inhibitor--hematological malignancies]. Gan To Kagaku Ryoho. 2001 May;28(5):601-7. Review. Japanese. PubMed PMID: 11383207.
4: Wheeler-Jones CP, May MJ, Morgan AJ, Pearson JD. Protein tyrosine kinases regulate agonist-stimulated prostacyclin release but not von Willebrand factor secretion from human umbilical vein endothelial cells. Biochem J. 1996 Apr 15;315 ( Pt 2):407-16. PubMed PMID: 8615807; PubMed Central PMCID: PMC1217210.
5: Poole AW, Watson SP. Regulation of cytosolic calcium by collagen in single human platelets. Br J Pharmacol. 1995 May;115(1):101-6. PubMed PMID: 7647963; PubMed Central PMCID: PMC1908739.
6: Watson SP, Poole A, Asselin J. Ethylene glycol bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA) and the tyrphostin ST271 inhibit phospholipase C in human platelets by preventing Ca2+ entry. Mol Pharmacol. 1995 Apr;47(4):823-30. PubMed PMID: 7723744.
7: Rodríguez-Liñares B, Watson SP. Phosphorylation of JAK2 in thrombin-stimulated human platelets. FEBS Lett. 1994 Oct 3;352(3):335-8. PubMed PMID: 7925997.
8: Martinson EA, Scheible S, Presek P. Inhibition of phospholipase D of human platelets by protein tyrosine kinase inhibitors. Cell Mol Biol (Noisy-le-grand). 1994 Jul;40(5):627-34. PubMed PMID: 7526916.
9: Blake RA, Asselin J, Walker T, Watson SP. Fc gamma receptor II stimulated formation of inositol phosphates in human platelets is blocked by tyrosine kinase inhibitors and associated with tyrosine phosphorylation of the receptor. FEBS Lett. 1994 Mar 28;342(1):15-8. PubMed PMID: 8143842.
10: Pettitt TR, Zaqqa M, Wakelam MJ. Epidermal growth factor stimulates distinct diradylglycerol species generation in Swiss 3T3 fibroblasts: evidence for a potential phosphatidylcholine-specific phospholipase C-catalysed pathway. Biochem J. 1994 Mar 15;298 Pt 3:655-60. PubMed PMID: 8141780; PubMed Central PMCID: PMC1137910.
11: Shiraishi T, Owada MK, Tatsuka M, Yamashita T, Watanabe K, Kakunaga T. Specific inhibitors of tyrosine-specific protein kinases: properties of 4-hydroxycinnamamide derivatives in vitro. Cancer Res. 1989 May 1;49(9):2374-8. PubMed PMID: 2706625.
